drugset / Trial / NCT06091410
Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines
RandomizedParallel-groupOpen-labelBasic science
Summary
The goal is to evaluate the in-depth immunogenicity analysis (including B-cell and T-cell response) of coadministration of a omicron-containing COVID-19 vaccine and influenza vaccine among healthy adults during 2023-24 season.
Timeline
- Start
- 2023-09-25
- Primary completion
- 2025-02-25
- Completion
- 2025-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | 0.5 ml | — |
| Subject | Omicron-containing COVID-19 vaccine | Messenger RNA (mRNA) | — | — |